Related Experiment Video
Updated: Feb 7, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Adjunct therapies to improve outcomes after botulinum toxin injection in children: A systematic review
L Mathevon1, I Bonan2, J-L Barnais3
1Department of Physical and Rehabilitation Medicine, CHU de Grenoble, 38000 Grenoble, France.
Insights
Adjunct therapies like casting improve spasticity and motion in children after botulinum toxin (BTX) injections. Resistance training also shows promise for muscle function, but more research is needed on other methods.
Area of Science:
- Pediatrics
- Neurology
- Rehabilitation Medicine
Background:
- Botulinum toxin (BTX) injections alone are insufficient for treating spasticity in children, particularly those with cerebral palsy.
- Adjunct therapies are increasingly used to enhance outcomes beyond BTX monotherapy.
Purpose of the Study:
- To systematically review the effectiveness of various adjunct therapies used in conjunction with BTX injections for pediatric spasticity.
Main Methods:
- A systematic review of Medline, Cochrane, and Embase databases (1980-2018) for parallel-group trials (RCTs and non-RCTs).
- Data extraction and risk of bias assessment using PEDro and Downs and Black scales.
- Inclusion of studies assessing adjunct therapies following BTX injection for spasticity in children.
Main Results:
- Twenty articles with 662 participants were included; RCTs were of good quality, non-RCTs of poor to moderate quality.
- Casting/posture combined with BTX improved range of motion and reduced spasticity compared to BTX alone (9 studies).
- Resistance training enhanced muscle quality and performance without increasing spasticity; rehabilitation programs showed encouraging results for activities.
Conclusions:
- Lower-limb casting with BTX has high evidence for improving spasticity and motion, but long-term efficacy and optimal timing require further study.
- Electrical stimulation data are inconclusive; resistance training is a promising adjunct to prevent strength loss.
- Rehabilitation programs require further evaluation as adjunct therapies post-BTX injection.
Background:
Botulinum toxin (BTX) injection alone is not sufficient to treat spasticity in children, notably those with cerebral palsy; thus, there is an emerging trend for adjunct therapies to offer greater outcomes than BTX alone.
Objective:
The aim of this systematic review was to evaluate the general effectiveness of adjunct therapies regardless of their nature in children with spasticity.
Methods:
Medline, Cochrane and Embase databases were searched from January 1980 to March 15, 2018 for reports of parallel-group trials (randomized controlled trials [RCTs] and non-RCTs) assessing adjunct therapies after BTX injection for treating spasticity in children. Two independent reviewers extracted data and assessed the risk of bias by using the PEDro scale for RCTs and Downs and Black scale (D&B) for non-RCTs.
Results:
Overall, 20 articles involving 662 participants met the inclusion criteria. The average quality was good for the 16 RCTs (mean PEDro score 7.4 [SD 1.6]) and poor to moderate for the 4 non-RCTs (D&B score 9 to 17). Adjunct therapies consisted of casting/posture, electrical stimulation, resistance training and rehabilitation programmes. Casting associated with BTX injection improved the range of passive and active motion and reduced spasticity better than did BTX alone (9 studies), with a follow-up of 1 year. Resistance training enhanced the quality and performance of muscles without increasing spasticity. Only 3 rehabilitation programmes were studied, with encouraging results for activities.
Conclusion:
Lower-limb posture with casting in children has a high level of evidence, but the long-term efficacy of short-leg casting needs to be evaluated. A comparison between the different modalities of casting is missing, and studies specifically devoted to testing the different kinds of casting are needed. Moreover, the delay to casting after BTX injection is not clear. Data on electrical stimulation are not conclusive. Despite the small number of studies, resistance training could be an interesting adjunct therapy notably to avoid loss of strength after BTX injection. Rehabilitation programmes after BTX injection still need to be evaluated.
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Heart Failure VI: Adjunct Therapies
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Predicting Reaction Outcomes

